Impact of dietary polyphenols on human platelet function--a critical review of controlled dietary intervention

Luisa M Ostertag1, Niamh O'Kennedy, Paul A Kroon

  • 1Rowett Institute of Nutrition and Health, University of Aberdeen, Aberdeen, UK.

Insights

Dietary polyphenols may protect against cardiovascular disease by inhibiting blood platelet activation. While cocoa products show consistent benefits, more research is needed on other polyphenols and standardized methods.

Area of Science:

  • Nutrition Science
  • Cardiovascular Health
  • Biochemistry

Background:

  • Cardiovascular disease (CVD) is a major health concern, influenced by factors including blood platelet activation.
  • Platelets contribute to atherosclerotic plaque formation and inflammatory processes.
  • Plant-based diets, rich in polyphenols, show protective effects against CVD.

Purpose of the Study:

  • To review human intervention studies on the effects of polyphenol-rich diets on platelet function.
  • To assess the evidence for dietary polyphenols in mitigating platelet-related cardiovascular risk.
  • To identify gaps in current research and suggest future directions.

Main Methods:

  • Systematic review of 25 human intervention studies.
  • Analysis of studies examining polyphenol-rich diets and platelet function markers.
  • Evaluation of diverse research methodologies and study designs.

Main Results:

  • Dietary polyphenols exhibit inhibitory effects on platelet function, both in vitro and in vivo.
  • Cocoa-derived products consistently demonstrate platelet-inhibiting effects at moderate intake levels.
  • Significant heterogeneity in study methods and outcomes leads to controversial assertions regarding other polyphenols.

Conclusions:

  • Cocoa polyphenols show promise in modulating platelet function for cardiovascular protection.
  • The bioavailability and efficacy of other dietary polyphenols require further investigation.
  • Standardized methodologies are crucial for future research on dietary polyphenols and platelet activity.

Related Concept Videos

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Structure and Function of Platelets01:18

Structure and Function of Platelets

The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...